Author:
Yuan You-Yuan,Cao Wen-Dong,Zhang Xiao-Hong,Du Rong-Xin,Wang Xue-Qi,Li Jing,Chen Juan,Yang Jun-Zi,Chen Jia-Qi
Abstract
Abstract
Objective
To explore the effect of a health (E)-coach chronic disease management model on the rehabilitation behaviour management of patients with arteriosclerosis obliterans (ASO).
Methods
The E-coach chronic disease management model was constructed based on a literature review and expert interviews. The effect of the E-coach model on patients with ASO during hospitalisation was analysed by comparing the compliance rates of blood glucose control, blood pressure control, drug compliance, ankle-brachial index, 6-min walking test (6MWT) and pain-free walking distance (PFWD) scores between the E-coach and control groups.
Results
In total, 212 patients with ASO were included in this study. After the intervention, the blood pressure compliance rate (44.8% vs. 65.7%) and blood glucose compliance rate (48.6% vs. 66.8%) were higher in the E-coach group than in the control group (p < 0.05). After intervention, compared with the control group, the patients in the E-coach group had better drug compliance (6.8 ± 1.9 vs. 7.9 ± 1.0), and the difference was statistically significant (p < 0.05). The scores for the 6MWT (329.19 ± 5.58 vs. 353.00 ± 9.76; 412.65 ± 12.59 vs. 499.16 ± 18.43) and PFWD (219.15 ± 11.96 vs. 225.36 ± 16.13; 331.62 ± 51.36 vs. 369.42 ± 75.71) tests were significantly higher in the E-coach group than in the control group at 1 and 6 months after intervention (p < 0.05).
Conclusion
The E-coach chronic disease management model can effectively improve the control rates of blood glucose and blood pressure and the behaviour management of patients with ASO and is thus worthy of clinical reference.
Funder
Construction of E-Coach Chronic Disease Management Model and Its Application in Rehabilitation Management of Patients Suffering Arteriosclerosis Obliterans
Publisher
Springer Science and Business Media LLC
Subject
Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health,Food Science
Reference21 articles.
1. Watanabe Y, Miyata T, Shigematsu K, Tanemoto K, Nakaoka Y, Harigai M, Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis (JPVAS). Current trends in epidemiology and clinical features of thromboangiitis obliterans in Japan- a nationwide survey using the medical support system database. Circ J. 2020;84(10):1786–96. https://doi.org/10.1253/circj.CJ-19-1165.
2. He Y, Xie C, Xia Y, Rang J, Peng L. Humanistic care interventions in patients with lower extremity arteriosclerosis obliterans. Am J Transl Res. 2021;13(9):10527–35.
3. Dua A, Lee CJ. Epidemiology of peripheral arterial disease and critical limb ischemia. Tech Vasc Interv Radiol. 2016;19(2):91–5. https://doi.org/10.1053/j.tvir.2016.04.001.
4. Claesson K, Kölbel T, Acosta S. Role of endovascular intervention in patients with diabetic foot ulcer and concomitant peripheral arterial disease. Int Angiol. 2011;30(4):349.
5. Zhang R, Lai ZC, Liu CW. Femoral-popliteal arteriosclerosis obliterans: review of evidence-based studies on drug-eluting endovascular treatment. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2019;41(2):256–60. https://doi.org/10.3881/j.issn.1000-503X.10849.